GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Carl R. who wrote (1975)	12/27/1999 1:39:00 PM
From: DanZ	Read Replies (1) of 5582

Carl, The only label that fits is homeopathic. They can't sell Zicam as a dietary supplement because Zicam is applied intranasally and nasal products can't be sold as dietary supplements. This actually works to the company's advantage because they are immune from the problems that Quigley faces with competition from zinc lozenges that are sold as dietary supplements. The Dietary Supplement Health and Education Act of 1994 (DSHEA) affords Quigley's competitors a loop hole to get around their license. Competitors can sell zinc lozenges as dietary supplements and avoid paying Quigley royalties. This has been a big problem for Quigley and has much to do with their decline in sales. At first I was concerned about the homeopathic designation because some people misconstrue it (like Wexler). However, consumers have proven that they don't care if Zicam is labeled as homeopathic because it is selling very well. If it works (and it has proven to me that it works), I think consumers will buy it and ignore the homeopathic designation. Dan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next